Clinical Trial Update: Observational, Safety Study of NovoNorm® (Repaglinide) and Insulin Analogue Combination Therapy in Type 2 Diabetes in Korea

View source ↗

Summary

This document reports a completed observational safety study of combining NovoNorm (repaglinide) with an insulin analogue in adults with Type 2 diabetes in Kore…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin analogue (insulin analogue)
• NovoNorm (repaglinide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Status: COMPLETED